Cargando…
Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm
[Image: see text] Targeted nanomedicine holds promise to find clinical use in many medical areas. Endothelial cells that line the luminal surface of blood vessels represent a key target for treatment of inflammation, ischemia, thrombosis, stroke, and other neurological, cardiovascular, pulmonary, an...
Autores principales: | Howard, Melissa, Zern, Blaine J., Anselmo, Aaron C., Shuvaev, Vladimir V., Mitragotri, Samir, Muzykantov, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046791/ https://www.ncbi.nlm.nih.gov/pubmed/24787360 http://dx.doi.org/10.1021/nn500136z |
Ejemplares similares
-
The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells
por: Pan, Daniel, et al.
Publicado: (2016) -
ICAM-1 Targeted Nanogels Loaded with Dexamethasone Alleviate Pulmonary Inflammation
por: Coll Ferrer, M. Carme, et al.
Publicado: (2014) -
Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells
por: Pan, Daniel C., et al.
Publicado: (2018) -
Targeting drug delivery in the vascular system: Focus on endothelium
por: Glassman, Patrick M., et al.
Publicado: (2020) -
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude
por: Brenner, Jacob S., et al.
Publicado: (2018)